Overview
Drug-induced cardiomyopathy arises from adverse effects of certain medications on cardiac muscle function, leading to impaired contractility and potential heart failure symptoms 1.Diagnosis
Elevated serum levels of implicated drugs (e.g., digoxin) may correlate with cardiomyopathy 1.
Cardiac biomarkers (e.g., troponin) can indicate myocardial injury 1.
Echocardiography or cardiac MRI to assess ventricular function and morphology 1.
Specific antibody assays for drug levels to confirm exposure and toxicity 1.Management
Discontinue the offending drug immediately upon suspicion 1.
Initiate supportive care including diuretics for fluid management 1.
Consider inotropic agents like digoxin alternatives (e.g., milrinone) if heart failure symptoms persist 1.
Close monitoring of cardiac function and electrolytes 1.Special Populations
No specific data provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.Key Recommendations
Use highly specific monoclonal antibodies for accurate measurement of drug levels to diagnose drug-induced cardiomyopathy (Evidence: Moderate) 1.
Prompt discontinuation of the suspected drug is crucial in managing drug-induced cardiomyopathy (Evidence: Expert opinion) 1.
Supportive measures including echocardiography for monitoring cardiac function are essential post-discontinuation (Evidence: Moderate) 1.References
1 Bång BE, Hurme M, Juntunen K, Mäkelä O. Studies of monoclonal and polyclonal anti-digoxin antibodies for serum digoxin radioimmunoassay. Scandinavian journal of clinical and laboratory investigation 1981. link